Monday, March 24

• Walgreen Company (NYSE: WAG) to report Q2 earnings; conference call at 8:30am.
• Tiffany & Co (NYSE: TIF) to report Q2 earnings; conference call at 8:30am.
• Glu Mobile Inc. (NASDAQ: GLUU) to hold a conference call at 5:00pm to discuss the acquisition of Superscape VR PLC (PINK: SCPDF).

Tuesday, March 25

• Jabil Circuit, Inc. (NYSE: JBL) to report Q2 earnings; conference call at 4:30pm.
• FDA Pediatric Advisory Committee at 8:00am on AstraZeneca PLC (ADR) (NYSE: AZN)'s Toprol XL, Baxter
  International, Inc. (NYSE: BAX) Brevibloc and Suprane, Novartis AG (ADR) (NYSE: NVS)'s Lotensin, GlaxoSmithKline plc (ADR) (NYSE: GSK)'s Coreg, Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP)'s Colazal, Sanofi-Aventis SA (ADR) (NYSE: SNY) 's Eloxatin, and Pfizer Inc. (NYSE: PFE)'s Celebrex.

Wednesday, March 26

• Oracle Corporation (NASDAQ: ORCL) to report Q3 earnings; conference call at 5:00pm.
• Response Genetics, Inc. (NASDAQ: RGDX) to give strategic update at 5:00pm.

Thursday, March 27

• TECO Energy, Inc. (NYSE: TE) to give updated 2008 outlook at 8:00am.
• Valeant Pharmaceuticals International (NYSE: VRX) to hold conference call at 12:00pm to review Taribavirin's Phase IIb results and the company's strategy.

Friday, March 28

• Steelcase Inc. (NYSE: SCS) to report Q4 earnings; conference call at 11:00am.
• Fed Reserve Bank St Louis: 8th Annual Conference in Columbia, MO.
• PDUFA date for QLT Inc. (USA) (NASDAQ: QLTI)'s Aczone Gel for the treatment of moderate to severe acne vulgaris.